AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
Gever JR, Soto R, Henningsen RA, Martin RS, Hackos DH, Panicker S, Rubas W, Oglesby IB, Dillon MP, Milla ME, Burnstock G, Ford AP.
Gever JR, et al. Among authors: martin rs.
Br J Pharmacol. 2010 Jul;160(6):1387-98. doi: 10.1111/j.1476-5381.2010.00796.x.
Br J Pharmacol. 2010.
PMID: 20590629
Free PMC article.